Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Lizinna 250 microgram /35 microgram Tablets

Active Ingredient:
norgestimate , ethinylestradiol
Company:  
Morningside Healthcare Ltd See contact details
ATC code: 
G03AA11
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Checklist for Prescribers - Lizinna

{healthcare_pro_orange} For Healthcare Professionals
Please use this checklist in conjunction with the SPC during combined hormonal contraceptives consultations. Risk of thromboembolism.
{pdf_link}

Important Information for Women - Lizinna

This is more information on recommendations of safety of combined hormonal contraceptives, in particular the risk of blood clots.
{pdf_link}

Patient Card - Lizinna

Important Information for women about risk of blood clots with combined hormonal contraceptives.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Morningside Healthcare Ltd
Company image
Address
Morningside House, Unit C Harcourt Way, Meridian Business Park, Leicester, LE19 1WP
WWW
http://www.morningsidehealthcare.com
Telephone
+44 (0)116 204 5950
Medical Information Direct Line
+44 (0)116 478 0322
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0)116 204 5950
Stock Availability
+44 (0)1509 217 705